Caribou Biosciences (CRBU) Revenue & Revenue Breakdown
Caribou Biosciences Revenue Highlights
Main Segment (Y)
Reportable Segment
Main Geography (Y)
UNITED STATES
Caribou Biosciences Revenue by Period
Caribou Biosciences Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | - | -100.00% |
| 2023-12-31 | $34.48M | 148.91% |
| 2022-12-31 | $13.85M | 44.31% |
| 2021-12-31 | $9.60M | -22.35% |
| 2020-12-31 | $12.36M | 113.56% |
| 2019-12-31 | $5.79M | - |
Caribou Biosciences generated - in revenue during NA 2024, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Caribou Biosciences Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-06-30 | - | -100.00% |
| 2025-03-31 | $2.35M | 13.29% |
| 2024-12-31 | $2.08M | 2.62% |
| 2024-09-30 | $2.02M | -41.57% |
| 2024-06-30 | $3.46M | 42.61% |
| 2024-03-31 | $2.43M | -31.73% |
| 2023-12-31 | $3.56M | -84.96% |
| 2023-09-30 | $23.66M | 530.15% |
| 2023-06-30 | $3.75M | 7.22% |
| 2023-03-31 | $3.50M | -5.15% |
| 2022-12-31 | $3.69M | 11.78% |
| 2022-09-30 | $3.30M | -21.21% |
| 2022-06-30 | $4.19M | 57.36% |
| 2022-03-31 | $2.66M | 4.10% |
| 2021-12-31 | $2.56M | -35.66% |
| 2021-09-30 | $3.98M | 169.44% |
| 2021-06-30 | $1.48M | -6.94% |
| 2021-03-31 | $1.59M | 61.18% |
| 2020-12-31 | $984.00K | -17.86% |
| 2020-09-30 | $1.20M | -85.87% |
| 2020-06-30 | $8.48M | 398.41% |
| 2020-03-31 | $1.70M | - |
Caribou Biosciences generated - in revenue during Q2 2025, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Caribou Biosciences Revenue Breakdown
Caribou Biosciences Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 24 |
|---|---|
| Reportable Segment | $9.99M |
Caribou Biosciences's latest annual revenue breakdown by segment (product or service), as of Dec 24: Reportable Segment (100.00%).
Quarterly Revenue by Product
| Product/Service | Jun 25 | Mar 25 |
|---|---|---|
| Reportable Segment | $2.67M | $2.35M |
Caribou Biosciences's latest quarterly revenue breakdown by segment (product or service), as of Jun 25: Reportable Segment (100.00%).
Caribou Biosciences Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|
| UNITED STATES | $9.27M | $32.77M | $13.30M | $8.91M |
| Non-US | $724.00K | $1.71M | $548.00K | $685.00K |
Caribou Biosciences's latest annual revenue breakdown by geography, as of Dec 24: UNITED STATES (92.76%), and Non-US (7.24%).
Quarterly Revenue by Country
| Country | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Mar 24 | Dec 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| UNITED STATES | $1.66M | $2.22M | $5.34M | $1.66M | $2.27M | $2.35M | $3.75M | $3.38M | $3.54M | $2.97M | $4.18M | $2.61M | $2.43M | $3.51M | $1.48M |
| Non-US | $1.00M | $129.00K | $197.00K | $367.00K | $160.00K | $1.20M | $9.00K | $117.00K | $150.00K | $337.00K | $9.00K | $52.00K | $129.00K | - | - |
| Non Us | - | - | - | - | - | - | - | - | - | - | - | - | - | $470.00K | $111.00K |
Caribou Biosciences's latest quarterly revenue breakdown by geography, as of Jun 25: UNITED STATES (62.32%), and Non-US (37.68%).
Caribou Biosciences Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| TRDA | Entrada Therapeutics | $210.78M | $20.56M |
| ENTA | Enanta Pharmaceuticals | $67.64M | $18.31M |
| SGMO | Sangamo Therapeutics | $57.80M | $6.44M |
| IVA | Inventiva | $17.48M | $2.73M |
| PYXS | Pyxis Oncology | $16.15M | - |
| ALLO | Allogene Therapeutics | $22.00K | - |
| IMRX | Immuneering | - | - |
| CRBU | Caribou Biosciences | - | - |
| SAVA | Cassava Sciences | - | - |
| SGMT | Sagimet Biosciences | - | - |
| AVIR | Atea Pharmaceuticals | - | - |